MIT Technology Review
MIT ke vaigyanikon ne T-cells ko badhakar cancer par hamla kiya
MIT ke shodhkartao ne mRNA adjuvant ke saath T-cell response ko badhakar cancer vaccines ko aur adhik prabhavi banaya, aur flu vaccines mein 15 guna adhik response prapt kiya - kyunki sookshmta overrated hai.